These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Saeed O; Otsuka F; Polavarapu R; Karmali V; Weiss D; Davis T; Rostad B; Pachura K; Adams L; Elliott J; Taylor WR; Narula J; Kolodgie F; Virmani R; Hong CC; Finn AV Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):299-307. PubMed ID: 22095982 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Maitra U; Li L Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):24-33. PubMed ID: 23117655 [TBL] [Abstract][Full Text] [Related]
6. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression. Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324 [TBL] [Abstract][Full Text] [Related]
7. Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. Li D; Wang D; Wang Y; Ling W; Feng X; Xia M J Biol Chem; 2010 Oct; 285(43):33499-33509. PubMed ID: 20713354 [TBL] [Abstract][Full Text] [Related]
8. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport. Chen X; Tang K; Peng Y; Xu X Can J Physiol Pharmacol; 2018 Jan; 96(1):8-17. PubMed ID: 28863273 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Larrede S; Quinn CM; Jessup W; Frisdal E; Olivier M; Hsieh V; Kim MJ; Van Eck M; Couvert P; Carrie A; Giral P; Chapman MJ; Guerin M; Le Goff W Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1930-6. PubMed ID: 19729607 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135 [TBL] [Abstract][Full Text] [Related]
11. Andrographolide Inhibits Oxidized LDL-Induced Cholesterol Accumulation and Foam Cell Formation in Macrophages. Lin HC; Lii CK; Chen HC; Lin AH; Yang YC; Chen HW Am J Chin Med; 2018; 46(1):87-106. PubMed ID: 29298513 [TBL] [Abstract][Full Text] [Related]
12. IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux. Rana M; Kumar A; Tiwari RL; Singh V; Chandra T; Dikshit M; Barthwal MK Bioessays; 2016 Jul; 38(7):591-604. PubMed ID: 27270491 [TBL] [Abstract][Full Text] [Related]
13. TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages. Zhao ZW; Zhang M; Zou J; Wan XJ; Zhou L; Wu Y; Liu SM; Liao LX; Li H; Qin YS; Yu XH; Tang CK Atherosclerosis; 2021 Jun; 327():76-86. PubMed ID: 33994201 [TBL] [Abstract][Full Text] [Related]
14. Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. Cui K; Gao X; Wang B; Wu H; Arulsamy K; Dong Y; Xiao Y; Jiang X; Malovichko MV; Li K; Peng Q; Lu YW; Zhu B; Zheng R; Wong S; Cowan DB; Linton M; Srivastava S; Shi J; Chen K; Chen H Circ Res; 2023 Jan; 132(1):e22-e42. PubMed ID: 36444722 [TBL] [Abstract][Full Text] [Related]
16. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein. Lv Y; Yang J; Gao A; Sun S; Zheng X; Chen X; Wan W; Tang C; Xie W; Li S; Guo D; Peng T; Zhao G; Zhong L Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):471-483. PubMed ID: 30950489 [TBL] [Abstract][Full Text] [Related]
17. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway. He XW; Yu D; Li WL; Zheng Z; Lv CL; Li C; Liu P; Xu CQ; Hu XF; Jin XP Biomed Pharmacother; 2016 Oct; 83():257-264. PubMed ID: 27389392 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice. Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus. Wang M; Wang D; Zhang Y; Wang X; Liu Y; Xia M Atherosclerosis; 2013 Jul; 229(1):62-70. PubMed ID: 23466101 [TBL] [Abstract][Full Text] [Related]
20. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1. Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]